scispace - formally typeset
Search or ask a question
Institution

LAC+USC Medical Center

HealthcareLos Angeles, California, United States
About: LAC+USC Medical Center is a healthcare organization based out in Los Angeles, California, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 1348 authors who have published 886 publications receiving 21927 citations. The organization is also known as: County/USC & Los Angeles County General.


Papers
More filters
Journal ArticleDOI
TL;DR: A 59-year-old male who presented with a pulsating pseudoaneurysm 15 months after placement of a HeartMate II left ventricular assist device is highlighted, a rare, but potentially fatal complication of a popular LVAD, the HeartMates II.

2 citations

Journal ArticleDOI
TL;DR: The 10-gauge angiocatheter (10g AC) was vastly superior to the 14g AC for return of spontaneous circulation following tPEA in the setting of 30% hemorrhage and further support the importance of larger caliber devices that facilitate rapid recovery from tPTX, particularly in theSetting of polytrauma.
Abstract: Background Little is known regarding the effect of hemorrhagic shock on the diagnosis and treatment of tension pneumothorax (tPTX). Recently, the Tactical Combat Casualty Care guidelines included the 10-gauge angiocatheter (10-g AC) as an acceptable alternative to the 14-g AC. This study sought to compare these two devices for decompression of tPTX and rescue from tension-induced pulseless electric activity (tPEA) in the setting of a concomitant 30% estimated blood volume hemorrhage. Methods Following a controlled hemorrhage, carbon dioxide was insufflated into the chest to induce either tPTX or tPEA. Tension pneumothorax was defined as a reduction in cardiac output by 50%, and tPEA was defined as a loss of arterial waveform with mean arterial pressure less than 20 mm Hg. The affected hemithorax was decompressed using a randomized 14-g AC or 10-g AC while a persistent air leak was maintained after decompression. Successful rescue from tPTX was defined as 80% recovery of baseline systolic blood pressure, while successful return of spontaneous circulation following tPEA was defined as a mean arterial pressure greater than 20 mm Hg. Primary outcome was success of device. Results Eighty tPTX and 50 tPEA events were conducted in 38 adult Yorkshire swine. There were no significant differences in the baseline characteristics between animals or devices. In the tPTX model, the 10-g AC successfully rescued 90% of events, while 14-g AC rescued 80% of events (p = 0.350). In the tPEA model, the 10-g AC rescued 87% of events while the 14 AC rescued only 48% of events (p = 0.006). Conclusion The 10-g AC was vastly superior to the 14-g AC for return of spontaneous circulation following tPEA in the setting of 30% hemorrhage. These findings further support the importance of larger caliber devices that facilitate rapid recovery from tPTX, particularly in the setting of polytrauma. Level of evidence Therapeutic, level II.

2 citations

Journal ArticleDOI
TL;DR: Class II interferons, produced by T-cells and natural killer cells, is made up of about 127 to 143 aminoacids and can induce arteriosclerotic changes in animals in the absence of detectable immunocytes by acting on vascular smooth cells.
Abstract: tant role in cell growth regulation and modulation of the immune system [1••]. There are two classes of interferons. The class I interferons can be produced by almost any cell type in response to viral and other infections. Interferon-α and interferon-β, class I interferons, are encoded by at least 18 genes clustered on chromosome 9. Made up of 165 or 166 amino acids, they have a molecular weight of about 20 kD. The class II interferon, interferon-γ, produced by T-cells and natural killer cells, is made up of about 127 to 143 aminoacids. It is encoded by a single gene on chromosome 12. It has a molecular weight of about 90 kD. Its effects are similar to those of the class I interferons but differ in having strong stimulating effects on the immune system. It can induce arteriosclerotic changes in animals in the absence of detectable immunocytes by acting on vascular smooth cells [2].

2 citations

Journal ArticleDOI
TL;DR: A tapered teflon dilator has been applied to 12 cases of percutaneous transluminal coronary angioplasty (PTCA) to assess the ability of a guidewire to cross a lesion to reduce cost.
Abstract: A tapered teflon dilator has been applied to 12 cases of percutaneous transluminal coronary angioplasty (PTCA). The technique was first used to predilate stenoses that could not initially be crossed with low profile over the wire PTCA balloons. In the first five cases, three angioplasties that would have been failures were converted to successes by this method. The dilator was used in place of a balloon catheter as an initial step to assess the ability of a guidewire to cross a lesion to reduce cost in five additional cases. Modification of an existing family of peripheral vascular dilators is described. The method of application of this technique to PTCA is outlined.

2 citations


Authors

Showing all 1361 results

NameH-indexPapersCitations
George A. Bray131896100975
Michael C. Fishbein11670150402
Keitaro Matsuo9781837349
Frank Z. Stanczyk9362030244
Demetrios Demetriades9374231887
Thomas A. Buchanan9134948865
George C. Velmahos9164628050
Mark D. Fleming8143336107
Kenji Inaba7979724806
Willa A. Hsueh7625418588
Lester D.R. Thompson7662227526
Ajit P. Yoganathan7462621612
Uri Elkayam7327927800
Yuan-Cheng Fung6921830827
Daniel R. Mishell6836314889
Network Information
Related Institutions (5)
NewYork–Presbyterian Hospital
25.3K papers, 1M citations

86% related

University of Texas Health Science Center at San Antonio
44.1K papers, 2.2M citations

85% related

Medical University of South Carolina
45.4K papers, 1.7M citations

85% related

Medical College of Wisconsin
41.5K papers, 1.7M citations

85% related

United States Department of Veterans Affairs
70.9K papers, 3.2M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20236
202212
202146
202041
201934
201829